Can serum gamma-glutamyltransferase levels be useful at diagnosing gestational diabetes mellitus?

Gynecological Endocrinology

Volumn 28, Issue 3, 2012, Pages 208-211

  Alanbay, Ibrahim ^a   Coksuer, Hakan ^a   Ercan, Mutlu ^a   Keskin, Ugur ^a   Karasahin, Emre ^a   Ozturk, Mustafa ^a   Tapan, Serkan ^a   Ozturk, Ozlem ^a   Kurt, Ismail ^a   Ergun, Ali ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Gamma glutamyltransferase; Gestational diabetes mellitus; Glucose challenge test; Glucose tolerance test; Pregnancy

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; METABOLIC PARAMETERS; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BODY MASS INDEX; DIABETES, GESTATIONAL; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIPIDS; LOGISTIC MODELS; PREGNANCY; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84856815123     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2011.588756     Document Type: Article

References (28)

1. International Association of Diabetes in Pregnancy Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classifcation of hyperglycemia in pregnancy. Diabetes Care 2010;33:676-682.
2. American Diabetes Association. Diagnosis and classifcation of diabetes mellitus. Diabetes Care 2006;29:S43-S44.
3. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, et al.; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991-2002. (Pubitemid 351656454)
4. The HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009;58:453-459.
5. Yogev, Chen, Hod, Coustan, Oats, McIntyre, Metzger, Lowe, Dyer, Dooley, Trimble, McCance, Hadden, Persson, Rogers; Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia. Am J Obstet Gynecol 2010;202:255.e1-7.
6. Reece EA. The fetal and maternal consequences of gestational diabetes mellitus. J Matern Fetal Neonatal Med 2010;23:199-203.
7. Bellamy L, Casas J P, Hingorani AD, Williams D. Type 2 diabetes mellitus afer gestational diabetes: a systematic review and meta-analysis. Lancet 2009;373:1773-1779.
8. Vohr BR, Boney CM. Gestational diabetes: the forerunner for the development of maternal and childhood obesity and metabolic syndrome? J Matern Fetal Neonatal Med 2008;21:149-157. (Pubitemid 351302424)
9. André P, Balkau B, Vol S, Charles MA, Eschwège E; DESIR Study Group. Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Defnition) in middle-aged men and women: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort. Diabetes Care 2007;30:2355-2361. (Pubitemid 47364644)
10. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, Stefes M. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003;49:1358-1366. (Pubitemid 36900623)
11. 2: the role of gamma-glutamyltransferase. Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetologia 2010;53:247-253.
12. Sabanayagam C, Shankar A, Li J, Pollard C, Ducatman A. Serum gamma-glutamyl transferase level and diabetes mellitus among US adults. Eur J Epidemiol 2009;24:369-373.
13. Ortega E, Koska J, Salbe AD, Tataranni PA, Bunt JC. Serum gamma-glutamyl transpeptidase is a determinant of insulin resistance independently of adiposity in Pima Indian children. J Clin Endocrinol Metab 2006;91:1419-1422.
14. Clinical management guidelines for obstetrician-gynecologists. ACOG Practice Bulletin No. 30. American College of Obstetricians and Gynecologists. Obstet Gynecol 2001;98:525-38.
15. Carpenter M W, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768-773. (Pubitemid 13196587)
16. Matthews DR, Hosker J P, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
17. Negrato CA, Jovanovic L, Tambascia MA, Calderon Ide M, Geloneze B, Dias A, Rudge M V. Mild gestational hyperglycaemia as a risk factor for metabolic syndrome in pregnancy and adverse perinatal outcomes. Diabetes Metab Res Rev 2008;24:324-330. (Pubitemid 351802798)
18. Nolan CJ. Controversies in gestational diabetes. Best Pract Res Clin Obstet Gynaecol 2011;25:37-49.
19. Lee JG, Lee S, Kim YJ, Jin HK, Cho BM, Kim YJ, Jeong D W, et al. Multiple biomarkers and their relative contributions to identifying metabolic syndrome. Clin Chim Acta 2009;408:50-55.
20. Kim C-H, Park J-Y, Lee K-U, Kim J-H, Kim H-K. Association of serum γ-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver. Diabetes Metab Res Rev 2009;25:64-69.
21. Derbent A, Kargili A, Koca C, Gümüs I,I, Sevgili S, Simavli S, Karakurt F, et al. Serum platelet-activating factor acetylhydrolase activity: relationship with metabolic syndrome in women with history of gestational diabetes mellitus. Gynecol Endocrinol 2011;27: 128-133.
22. Tan PC, Mubarak S, Omar SZ. Gamma-glutamyltransferase level in pregnancy is an independent risk factor for gestational diabetes mellitus. J Obstet Gynaecol Res 2008;34:512-517.
23. Wen J, Liang Y, Wang F, Sun L, Guo Y, Duan X, Liu X, et al. C-reactive protein, gamma-glutamyltransferase and type 2 diabetes in a Chinese population. Clin Chim Acta 2010;411:198-203.
24. Lee CC, Adler AI, Sandhu MS, Sharp SJ, Forouhi NG, Erqou S, Luben R, et al. Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis. Diabetologia 2009;52:1040-1047.
25. van Leeuwen M, Opmeer BC, Zweers EJ, van Ballegooie E, ter Brugge HG, de Valk H W, Visser GH, et al. Estimating the risk of gestational diabetes mellitus: a clinical prediction model based on patient characteristics and medical history. BJOG 2010;117:69-75.
26. Tan PC, Jacob R, Quek KF, Omar SZ. Pregnancy outcome in hyperemesis gravidarum and the efect of laboratory clinical indicators of hyperemesis severity. J Obstet Gynaecol Res 2007;33:457-464. (Pubitemid 47222722)
27. Samuel V T, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ, et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 2004;279:32345-32353. (Pubitemid 39014687)
28. Samuel V T, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ, Shulman GI. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 2004;279:32345-32353. (Pubitemid 39014687)